Key result
Comprehensive review outlines CKD management, current treatment strategies, and emerging pipeline drugs.
Why the study?
Prevalence of CKD is increasing worldwide, with patients affected by care costs, dialysis and transplantation, and lack of awareness and strategy implementation in rural areas.
This review provides a comprehensive overview of the epidemiology, diagnosis, and management strategies for chronic kidney disease.
Consolidates CKD management for clinicians; leaves open rigorous trials of pipeline agents before adoption.
Chronic kidney diseases (CKD) are an important public health concern worldwide. In developed as well in less-developed countries, prevalence of CKD is increasing day by day. Large numbers of people are affected by cost of care, dialysis and transplantation treatment strategies and lack of awareness in rural areas and implementation of treatment strategies. Primordial prevention of CKD can be achieved through implementation of measures to ensure healthy development by working on new treatment strategies, accepting new processes of prevention and covering gaps found during the previous data created. This review work is aimed to compile in depth literature on CKD; majorly relationship between acute kidney injuries (AKI), CKD and end stage renal disease (ESRD) causes and different stages of CKD, prevalence or epidemiology and global current status. Diagnosis parameters, current treatment strategies along with traditional medicines and new pipeline drugs on CKD are described in detail for prevention and treatment of CKD, along with gap analysis.
No takes yet. Share an insight, caveat, or question.
Kapare et al. (2022) conducted a review in Chronic kidney diseases (CKD). This review provides a comprehensive overview of chronic kidney disease management, including epidemiology, diagnosis, current treatment strategies, and new pipeline drugs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: